Olverembatinib (GZD824) dimesylate is a third-generation oral effective BCR-ABL inhibitor, acting on BCR-ABL (WT) and BCR-ABL (T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
Molecular Weight:
724.77
Purity:
99.30%
CAS Number:
[1421783-64-3]
Formula:
C29H27F3N6O.2CH4O3S
Target:
Src-bcr-Abl
* VAT and and shipping costs not included. Errors and price changes excepted